Investor profile
Octave Fund
Micro-fund
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Octave is an early-stage, founder-centric fund investing in enterprise data opportunities. Founded by Will Smith, a former founder who built and exited Euclid (an enterprise data company acquired by WeWork), the fund champions founders focused on enterprise data at the earliest stages with checks of $300k–$750k. The firm believes machine learning is the transformative technology of our time and is excited by new ideas that help unlock the power of ML by solving key problems in Infrastructure, Applied ML, Dev Tools, and Security & Privacy. As grizzled former founders, the team takes a hands-on, high-touch approach — supporting portfolio companies from the tactical to the personal.
Notable quotes
“I believe you can spot a great company first in its founders and then in its product, well before anything shows up in a spreadsheet.”
“As grizzled former founders, we understand that the startup journey, in the best case, is equal parts disaster and glory.”
“Data is at its Kitty Hawk moment and we're thrilled to be a lifting force for the next generation of founders.”
Team
Will Smith
General Partner & Founder
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Springtail | Seed | — | 2025-04-09 |
| Bounti | Seed | $16m | 2024-09-12 |
| Haus Analytics | Series A | $20m | 2024-07-30 |
| Safety Cybersecurity | Seed | — | 2024-06-01 |
| Weights & Biases | Series A | $5m | 2018-05-31 |
| Notion | Seed | — | — |
| Datavant | Seed | — | — |
| Transcend | Seed | — | — |
| Metronome | Seed | — | — |
| Forethought | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Bloomberg Beta | 3 |
| Insight Partners | 2 |
| Coatue Management | 2 |
| Sequoia Capital | 2 |
| Floodgate | 1 |
| Trinity Ventures | 1 |
Fit check
Is Octave Fund a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit